We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen Announces Inhibition of Angiogenesis by Novel Peptide

News   Apr 03, 2009

 
Compugen Announces Inhibition of Angiogenesis by Novel Peptide
 
 
 

RELATED ARTICLES

Genetics Reveal New Treatment Options for Osteoarthritis

News

In the largest genetic study of osteoarthritis to date, scientists have uncovered 52 new genetic changes linked to the disease, which doubles the number of genetic regions associated with the disabling condition.

READ MORE

Artificially Produced Cells Communicate with Each Other

News

The cells, separated by fatty membranes, exchange small chemical signaling molecules to trigger more complex reactions, such as the production of RNA and other proteins.

READ MORE

Targeting Tiny "Pocket" to Treat Stroke and Seizure

News

The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE